BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31202500)

  • 1. Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension.
    Lai YJ; Chen PR; Huang YL; Hsu HH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):300-309. PubMed ID: 31202500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
    Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
    J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease.
    Khoury S; Beauvais A; Colas J; Saint-Martin Willer A; Perros F; Humbert M; Vandebrouck C; Montani D; Ferreira T; Antigny F
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease.
    Manaud G; Nossent EJ; Lambert M; Ghigna MR; Boët A; Vinhas MC; Ranchoux B; Dumas SJ; Courboulin A; Girerd B; Soubrier F; Bignard J; Claude O; Lecerf F; Hautefort A; Florio M; Sun B; Nadaud S; Verleden SE; Remy S; Anegon I; Bogaard HJ; Mercier O; Fadel E; Simonneau G; Vonk Noordegraaf A; Grünberg K; Humbert M; Montani D; Dorfmüller P; Antigny F; Perros F
    Am J Respir Cell Mol Biol; 2020 Jul; 63(1):118-131. PubMed ID: 32209028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.
    Zhang L; Wang Y; Zhang R
    Medicine (Baltimore); 2021 Oct; 100(41):e27334. PubMed ID: 34731104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
    Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
    Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study.
    Overbeek MJ; Boonstra A; Voskuyl AE; Vonk MC; Vonk-Noordegraaf A; van Berkel MP; Mooi WJ; Dijkmans BA; Hondema LS; Smit EF; Grünberg K
    Arthritis Res Ther; 2011 Apr; 13(2):R61. PubMed ID: 21492463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary capillary haemangiomatosis: a distinct entity?
    Weatherald J; Dorfmüller P; Perros F; Ghigna MR; Girerd B; Humbert M; Montani D
    Eur Respir Rev; 2020 Jun; 29(156):. PubMed ID: 32461209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis.
    Chazova I; Robbins I; Loyd J; Newman J; Tapson V; Zhdaov V; Meyrick B
    Eur Respir J; 2000 Jan; 15(1):116-22. PubMed ID: 10678631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
    Eyries M; Montani D; Girerd B; Perret C; Leroy A; Lonjou C; Chelghoum N; Coulet F; Bonnet D; Dorfmüller P; Fadel E; Sitbon O; Simonneau G; Tregouët DA; Humbert M; Soubrier F
    Nat Genet; 2014 Jan; 46(1):65-9. PubMed ID: 24292273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of pulmonary veno-occlusive disease.
    Solinas S; Boucly A; Beurnier A; Kularatne M; Grynblat J; Eyries M; Dorfmüller P; Sitbon O; Humbert M; Montani D
    Expert Rev Respir Med; 2023; 17(8):635-649. PubMed ID: 37578057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
    Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
    Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary veno-occlusive disease: illustrative cases and literature review.
    Lechartier B; Boucly A; Solinas S; Gopalan D; Dorfmüller P; Radonic T; Sitbon O; Montani D
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38232988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease.
    Chen Z; Zhang J; Wei D; Chen J; Yang J
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):677-689. PubMed ID: 33988041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: pulmonary veno-occlusive disease: a rare but fatal cause of pulmonary hypertension in a patient following allogeneic stem cell transplantation.
    Katrien M; Dieter S; Anke D; Amelie D; De Pauw M; Eric D
    Acta Clin Belg; 2022 Jun; 77(3):697-702. PubMed ID: 34191691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid disease progress in a PVOD patient carrying a novel EIF
    Zeng X; Chen F; Rathinasabapathy A; Li T; Adnan Ali Mohammed Mohammed A; Yu Z
    BMC Pulm Med; 2020 Jul; 20(1):186. PubMed ID: 32631303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Veno-Occlusive Disease: A Newly Recognized Cause of Severe Pulmonary Hypertension in Dogs.
    Williams K; Andrie K; Cartoceti A; French S; Goldsmith D; Jennings S; Priestnall SL; Wilson D; Jutkowitz A
    Vet Pathol; 2016 Jul; 53(4):813-22. PubMed ID: 26926086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.
    Montani D; Lau EM; Descatha A; Jaïs X; Savale L; Andujar P; Bensefa-Colas L; Girerd B; Zendah I; Le Pavec J; Seferian A; Perros F; Dorfmüller P; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2015 Dec; 46(6):1721-31. PubMed ID: 26541523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of medical therapy in pulmonary arterial hypertension. Is there an alternative diagnosis?
    Harch S; Whitford H; McLean C
    Chest; 2009 Jun; 135(6):1462-1469. PubMed ID: 19188548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary veno-occlusive disease.
    Montani D; Lau EM; Dorfmüller P; Girerd B; Jaïs X; Savale L; Perros F; Nossent E; Garcia G; Parent F; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2016 May; 47(5):1518-34. PubMed ID: 27009171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.